AssayIndex

TFC-2508-W6939

Epitalon · 20 mg declared · Tianjin Finder Chemical Co., Ltd. · manufactured 15 Aug 2025

CHARACTERISED
Lot code
TFC-2508-W6939
Supplier
TFC — Tianjin Finder Chemical Co., Ltd.
Compound
Epitalon
Compound class
Short bioregulator peptides
Declared label claim
20mg
Manufacture date
15 Aug 2025
Index quarter
2026-Q1
Independent assays
10
Laboratories involved
Janoshik, VendorInvestigate, Kestrel, PeptideMeter, Medutest, Nordanalyt
Provenance mix
Buyer-sourced ×9 · Supplier-supplied ×1
Section 1

Reproducibility across independent tests

Every report below is an observation of the same physical material. What they disagree about is measurement; what they agree about is the lot. The size of the disagreement is compared against what the contributing laboratories' own repeatability figures predict.

Independent assays 10
Median purity 99.01% n=10
Spread (max − min) 1.06pp n=10
Standard deviation 0.345pp n=10
97.597.998.498.899.299.7100.1This lot (TFC-2508-W6939)This lot (TFC-2508-W6939): Q1 98.83, median 99.00, Q3 99.15, n=10outlier 99.82n=10All EpitalonAll Epitalon: Q1 98.78, median 99.63, Q3 99.92, n=70n=70 Purity (% area)
Figure 1. This lot's independent purity results against the whole Epitalon record set in the index. The vertical line is the index acceptance specification for the short bioregulator peptides class, 99.0 % area. A narrow box on the top row against a wide box on the bottom row is the ideal reading: it means the disagreement between lots is much larger than the disagreement within this one.
Section 2

Member reports 10

Every report the index holds on this lot. Each is a page carrying its own chromatogram, mass spectrum, mass balance, provenance and caveats.

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042070TFC-2508-W6939Janoshik2026-Q199.146.81Buyer-sourced0FAIL
AX-2026-042071TFC-2508-W6939VendorInvestigate2026-Q199.156.76Buyer-sourced0FAIL
AX-2026-042072TFC-2508-W6939VendorInvestigate2026-Q198.846.36Buyer-sourced0FAIL
AX-2026-042073TFC-2508-W6939Kestrel2026-Q199.827.13Buyer-sourced0FAIL
AX-2026-042074TFC-2508-W6939PeptideMeter2026-Q199.516.72Supplier-supplied1FAIL
AX-2026-042075TFC-2508-W6939Medutest2026-Q198.897.2899.1Buyer-sourced0FAIL
AX-2026-042076TFC-2508-W6939Nordanalyt2026-Q199.126.74Buyer-sourced0FAIL
AX-2026-042077TFC-2508-W6939Medutest2026-Q198.766.6992.1Buyer-sourced0FAIL
AX-2026-042078TFC-2508-W6939Janoshik2026-Q198.826.64104.1Buyer-sourced0FAIL
AX-2026-042079TFC-2508-W6939Janoshik2026-Q198.836.86106.9Buyer-sourced1FAIL
Section 3

By laboratory

Where more than one laboratory assayed this lot, the difference between them is a paired observation of their relative bias — the same material, the same time window, different instruments. Those pairs are what the index's bias estimates are built from.

LaboratoryReportsPurity results (% area)MedianGradientPublished bias (pp)Bias-adjusted
Janoshik399.14, 98.82, 98.8398.8330min+0.0098.83
VendorInvestigate299.15, 98.8499.0032min-0.1199.11
Kestrel199.8299.8215min+0.2499.58
PeptideMeter199.5199.5128min-0.0599.56
Medutest298.89, 98.7698.8325min+0.0898.75
Nordanalyt199.1299.1235min+0.0299.10

This lot contributes 15 paired comparisons to the inter-lab analysis.

Section 4

The supplier's certificate for this lot

One number the supplier wrote, beside the median of the numbers other people measured on the same physical material. That comparison is only available because the index groups by lot.

FigureSupplier COAThis reportIndex note
Purity (% area)98.9999.14divergence -0.02 pp vs batch median
Total impurities (% area)1.010.86
Largest single impurity (% area)0.610.50
Water (%)6.16.81
Counter-ion (%)not stated13.79
Peptide content (%w/w)89.1not determined
Endotoxin (EU/mg)0.48not determined
Method stated on certificateYEScolumn, gradient and wavelength given
Section 5

Impurity fingerprint

The named impurities reported across this lot's assays, with how consistently each was seen. A fingerprint is what allows two lot numbers held by different companies to be identified as one bulk.

Named impurityReported inMedian % areaRange
β-Asp isomer10 / 100.450.04–0.68
Ala-Glu-Asp tripeptide (−57 Da)10 / 100.320.09–0.54
diketopiperazine (−18 Da)10 / 100.110.04–0.14
aspartimide (−18 Da)9 / 100.070.03–0.10
Section 7

What this rollup does not establish